Biomarker identification in bipolar disorder

2025/02/17 by Francesca Martella, Andrea Caporali, Monica Macellaro +7
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Biology #Biomarker #Bipolar Disorder and Treatment #Bipolar disorder #Genetics #Genetics and Neurodevelopmental Disorders #Identification (biology) #Internal medicine #Lithium (medication) #Medicine #Tryptophan and brain disorders

paper · doi:10.1016/j.pharmthera.2025.108823

openalex publication_date 2025/02/17 · openalex created_date 2025/02/18 · openalex updated_date 2026/07/30

Citations

• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
• Toward a Comprehensive Clinical Staging Model for Bipolar Disorder: Integrating the Evidence
• A quantitative meta-analysis of fMRI studies in bipolar disorder
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation
• Strategies to Reduce Misdiagnosis of Bipolar Depression
• The Brain's Default Network
• Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
• The Brain's Default Mode Network
• Experimental strategies for microRNA target identification
• The role of DNA methylation in the pathophysiology and treatment of bipolar disorder
• Dynamic functional connectivity in bipolar disorder is associated with executive function and processing speed: A preliminary study.
• Resting state functional network switching rate is differently altered in bipolar disorder and major depressive disorder